No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Why Marvell Technology Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Express News | Viracta Therapeutics Inc - Receives Notice of Non-Compliance From Nasdaq
Viracta Therapeutics Is Maintained at Outperform by RBC Capital
RBC Cuts Price Target on Viracta Therapeutics to $2 From $4, Keeps Outperform, Speculative Risk
Viracta Therapeutics | 10-Q: Q3 2024 Earnings Report
No Data